AC
ITCI

Aaron Cowen’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Aaron Cowen’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-700,904
Closed -$92.5M – 112
2025
Q1 		$92.5M Sell
700,904
-738,122
-51% -$92M 3.43% 9
2024
Q4 		$120M Hold
1,439,026
– – 4.1% 4
2024
Q3 		$105M Sell
1,439,026
-126,970
-8% -$9.54M 3.37% 5
2024
Q2 		$107M Buy
1,565,996
+606,798
+63% +$42.1M 3.94% 5
2024
Q1 		$66.4M Sell
959,198
-206,750
-18% -$14.2M 2.47% 12
2023
Q4 		$83.5M Sell
1,165,948
-203,901
-15% -$11.7M 3.78% 7
2023
Q3 		$71.4M Buy
1,369,849
+170,878
+14% +$9.96M 3.86% 9
2023
Q2 		$75.9M Hold
1,198,971
– – 4.06% 5
2023
Q1 		$64.9M Buy
1,198,971
+162,023
+16% +$7.83M 2.74% 11
2022
Q4 		$54.9M Buy
1,036,948
+184,990
+22% +$9.27M 2.3% 15
2022
Q3 		$39.6M Sell
851,958
-486,742
-36% -$25.4M 1.65% 27
2022
Q2 		$76.4M Sell
1,338,700
-193,223
-13% -$11M 2.91% 8
2022
Q1 		$93.7M Buy
1,531,923
+279,977
+22% +$14.5M 2.86% 9
2021
Q4 		$65.5M Hold
1,251,946
– – 1.27% 28
2021
Q3 		$46.7M Buy
1,251,946
+213,176
+21% +$7.41M 0.79% 37
2021
Q2 		$42.4M Hold
1,038,770
– – 0.63% 41
2021
Q1 		$35.2M Buy
1,038,770
+132,800
+15% +$4.61M 0.52% 46
2020
Q4 		$28.8M Buy
905,970
+413,700
+84% +$10.9M 0.41% 48
2020
Q3 		$12.6M Buy
+492,270
New +$11.2M 0.23% 48

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Aaron Cowen's ITCI Position: Q2 2025 in Review

Aaron Cowen sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 700,904 shares — an estimated $92.5M sold.

Aaron Cowen first reported a position in ITCI in Q3 2020 and held it in 19 quarters. The position peaked at $120M in Q4 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Aaron Cowen reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Aaron Cowen sold 700,904 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $92.5M.
  • Aaron Cowen first reported a position in Intra-Cellular Therapies Inc. in Q3 2020 and held it in 19 quarters.
  • Aaron Cowen's Intra-Cellular Therapies Inc. position peaked at $120M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Suvretta Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.